JP2005531604A5 - - Google Patents

Download PDF

Info

Publication number
JP2005531604A5
JP2005531604A5 JP2004509705A JP2004509705A JP2005531604A5 JP 2005531604 A5 JP2005531604 A5 JP 2005531604A5 JP 2004509705 A JP2004509705 A JP 2004509705A JP 2004509705 A JP2004509705 A JP 2004509705A JP 2005531604 A5 JP2005531604 A5 JP 2005531604A5
Authority
JP
Japan
Prior art keywords
preparation
per
article
manufacture
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004509705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531604A (ja
Filing date
Publication date
Priority claimed from US10/159,083 external-priority patent/US6830744B2/en
Application filed filed Critical
Publication of JP2005531604A publication Critical patent/JP2005531604A/ja
Publication of JP2005531604A5 publication Critical patent/JP2005531604A5/ja
Pending legal-status Critical Current

Links

JP2004509705A 2002-05-31 2003-04-08 組換え型ヒトインターフェロンα−２ｂの肺送達のための組成物、方法およびシステム Pending JP2005531604A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/159,083 US6830744B2 (en) 2002-05-31 2002-05-31 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
PCT/US2003/010832 WO2003102014A2 (en) 2002-05-31 2003-04-08 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b

Publications (2)

Publication Number Publication Date
JP2005531604A JP2005531604A (ja) 2005-10-20
JP2005531604A5 true JP2005531604A5 (https=) 2006-07-06

Family

ID=29582814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004509705A Pending JP2005531604A (ja) 2002-05-31 2003-04-08 組換え型ヒトインターフェロンα−２ｂの肺送達のための組成物、方法およびシステム

Country Status (6)

Country Link
US (1) US6830744B2 (https=)
EP (1) EP1515744A4 (https=)
JP (1) JP2005531604A (https=)
AU (1) AU2003221700A1 (https=)
CA (1) CA2484626A1 (https=)
WO (1) WO2003102014A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10134650B4 (de) * 2001-07-20 2009-12-03 Roche Diagnostics Gmbh System zur Entnahme kleiner Körperflüssigkeitsmengen
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
ITMI20032067A1 (it) * 2003-10-23 2005-04-24 Unihart Corp Formulazione spray per il trattamento delle infezioni virali.
CN101522244B (zh) * 2006-08-01 2013-06-26 日本烟草产业株式会社 气雾吸引器
CN103209728B (zh) * 2010-09-24 2015-10-14 多诺万·B.·耶茨 紧凑、低流阻的气溶胶发生器及其操作方法
CN105310988B (zh) * 2015-11-23 2018-05-04 哈药集团生物工程有限公司 一种含有重组人干扰素α2b的冻干药物组合物
CN113491807B (zh) * 2020-04-03 2023-07-28 深圳麦克韦尔科技有限公司 一种气溶胶产生装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262575D1 (en) 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5709202A (en) 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6131570A (en) 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
KR100399156B1 (ko) * 1999-11-19 2003-09-26 주식회사 엘지생명과학 α-인터페론의 용액제형
KR20020072563A (ko) 1999-12-30 2002-09-16 인터뮨, 인크. γ―ＩＦＮ 액체―소적 에어로졸 및 방법
WO2001080897A2 (en) * 2000-04-21 2001-11-01 Vical Incorporated Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
IN191090B (https=) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
AU2587002A (en) * 2000-11-03 2002-05-15 Biomedicines Inc Method for short-term and long-term drug dosimetry

Similar Documents

Publication Publication Date Title
AU2020200290B2 (en) Heat-stable dry powder pharmaceutical compositions and methods
CA1292182C (en) Intrapulmonary delivery of polypeptide growth factors and cytokines
AU753673B2 (en) Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
CN1292714B (zh) 气溶胶化活性剂的输送
KR100466486B1 (ko) 에어러졸화된약제의폐전달
US6616914B2 (en) Method for pulmonary and oral delivery of pharmaceuticals
CA2464250C (en) Kit for the preparation of a pharmaceutical composition
CN101804230B (zh) 流阻调节的气雾化活性剂给药
US6509006B1 (en) Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US20060239930A1 (en) Process for nebulizing aqueous compositions containing highly concentrated insulin
RU2002134467A (ru) Способ высокоэффективной доставки аэрозоля с большой терапевтической массой
JP2004534763A5 (https=)
AU2002350622A1 (en) Kit for the preparation of a pharmaceutical composition
US6187765B1 (en) Mometasone furoate suspensions for nebulization
EP1033991B1 (en) Mometasone furoate suspensions for nebulization
IT202000005026A1 (it) Lattoferrina per uso inalatorio ad azione antivirale
JP2005531604A5 (https=)
CN103153315A (zh) 用吸入地纽福索治疗囊性纤维化的方法
WO2001015777A1 (en) Pulmonary-administration of mineral ascorbates
HK1033438A (en) Aerosolized active agent delivery